Call for Medical Research Companies: Partnering with DB Biotech. Priority for IATI Members!Dec. 7, 2017
DB Biotech, a Slovak producer of high quality antibodies used for clinical diagnostics and/or research of early cancer, leukaemia, neurodegenerative, immune system related diseases and others is looking for Israeli partners in the following fields:
- Help (know-how, expertise, unique technology, capacities) with development of new antibodies for clinical diagnosis and/or research (early cancer, neurodegenerative diseases, leukemias, immune mediated diseases, etc.);
- Expertise in research of neurodegenerative diseases (Huntington Ds, prion related diseases);
Proteomic Services, expertise and know-how;
- Capacities for production of antibodies for e.g. pharma businesses developing new drugs, testing kits, etc.
DB Biotech has a portfolio of 140 products, sold worldwide. The company has ISO 9001:2015 and ISO 13485:2016 certificates (Lloyd’s Register LRQA, London, UK), and its products are IVD CE certified. The company is able to design and produce custom made proteins by using its own proteomic laboratory with the possibility to identify any protein connected to possible pathology and simultaneously develop corresponding original antibodies.
If interested, please send a paragraph describing your company's work, as well as its One Pager to email@example.com by Dec 7th, 2017.